HCV New Drug Research: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus
Links shared publicly online about this topic.
- 347total visits
HCV New Drug Research: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus
hepatitiscnewdrugs.blogspot.com —
HCV New Drug Research: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus
View full resource at hepatitiscnewdrugs.blogspot.com
Tags: Liver, Hepatitis, Hepatitis C Medication, Organ Transplantation, Drug, Rebetol, Transplantation
Most Recently Shared on April 22, 2011 at 12:27 pm By:
Tina Banwart - HepatitisCNewDrugs
A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic… http://goo.gl/fb/rCeLE
Advertisement
